Sign In

Login

Password

Forgot Password ? Sign Up

Maladie non transmissible (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Maladie non transmissible" in French language version.

refsWebsite
Global rank French rank
9who.int
195th place
221st place
9nih.gov
4th place
12th place
7doi.org
2nd place
3rd place
2un.org
97th place
106th place
1thelancet.com
2,393rd place
506th place
1sciencesetavenir.fr
5,021st place
272nd place
1phac-aspc.gc.ca
low place
5,972nd place
1web.archive.org
1st place
1st place
1wikiwix.com
194th place
17th place
1archive.is
87th place
20th place
1googleusercontent.com
243rd place
21st place
1ncdalliance.org
low place
low place
1annals.org
low place
1,894th place

annals.org

archive.is

doi.org

dx.doi.org

  • (en) Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M, « Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors », Lancet, vol. 366, no 9499,‎ , p. 1784–93 (PMID 16298215, DOI 10.1016/S0140-6736(05)67725-2).
  • (en) M Karakas et W Koenig, « CRP in cardiovascular disease », Herz, vol. 34, no 8,‎ , p. 607–13 (PMID 20024640, DOI 10.1007/s00059-009-3305-7).
  • (en) W Lieb, P Gona, MG Larson, JM Massaro, I Lipinska, JF Keaney Jr, J Rong, D Corey et U Hoffmann, « Biomarkers of the osteoprotegerin pathway: Clinical correlates, subclinical disease, incident cardiovascular disease, and mortality », Arteriosclerosis, thrombosis, and vascular biology, vol. 30, no 9,‎ , p. 1849–54 (PMID 20448212, PMCID 3039214, DOI 10.1161/ATVBAHA.109.199661).
  • (en) SM Venuraju, A Yerramasu, R Corder et A Lahiri, « Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity », Journal of the American College of Cardiology, vol. 55, no 19,‎ , p. 2049–61 (PMID 20447527, DOI 10.1016/j.jacc.2010.03.013).
  • DM Nathan, PA Cleary, JY Backlund, SM Genuth, JM Lachin, TJ Orchard, P Raskin, B Zinman et Diabetes Control Complications Trial/Epidemiology of Diabetes Interventions Complications (DCCT/EDIC) Study Research Group, « Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes », The New England Journal of Medicine, vol. 353, no 25,‎ , p. 2643–53 (PMID 16371630, PMCID 2637991, DOI 10.1056/NEJMoa052187).
  • « The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group », Annals of Internal Medicine, vol. 122, no 8,‎ , p. 561–8 (PMID 7887548, DOI 10.1059/0003-4819-122-8-199504150-00001, lire en ligne).
  • Zhang, Q.L. & Rothenbacher, D., « Prevalence of chronic kidney disease in population-based studies: systematic review », BMC Public Health, vol. 8,‎ , p. 117 (PMID 18405348, PMCID 2377260, DOI 10.1186/1471-2458-8-117).

googleusercontent.com

webcache.googleusercontent.com

ncdalliance.org

  • (en) The NCD Alliance, « About Us », The NCD Alliance (consulté le ).

nih.gov

ncbi.nlm.nih.gov

  • Boutayeb A, Boutayeb S. « The burden of non communicable diseases in developing countries », Int J Equity Health, 2005; 4:2 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC546417/
  • (en) Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M, « Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors », Lancet, vol. 366, no 9499,‎ , p. 1784–93 (PMID 16298215, DOI 10.1016/S0140-6736(05)67725-2).
  • (en) M Karakas et W Koenig, « CRP in cardiovascular disease », Herz, vol. 34, no 8,‎ , p. 607–13 (PMID 20024640, DOI 10.1007/s00059-009-3305-7).
  • (en) W Lieb, P Gona, MG Larson, JM Massaro, I Lipinska, JF Keaney Jr, J Rong, D Corey et U Hoffmann, « Biomarkers of the osteoprotegerin pathway: Clinical correlates, subclinical disease, incident cardiovascular disease, and mortality », Arteriosclerosis, thrombosis, and vascular biology, vol. 30, no 9,‎ , p. 1849–54 (PMID 20448212, PMCID 3039214, DOI 10.1161/ATVBAHA.109.199661).
  • (en) SM Venuraju, A Yerramasu, R Corder et A Lahiri, « Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity », Journal of the American College of Cardiology, vol. 55, no 19,‎ , p. 2049–61 (PMID 20447527, DOI 10.1016/j.jacc.2010.03.013).
  • DM Nathan, PA Cleary, JY Backlund, SM Genuth, JM Lachin, TJ Orchard, P Raskin, B Zinman et Diabetes Control Complications Trial/Epidemiology of Diabetes Interventions Complications (DCCT/EDIC) Study Research Group, « Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes », The New England Journal of Medicine, vol. 353, no 25,‎ , p. 2643–53 (PMID 16371630, PMCID 2637991, DOI 10.1056/NEJMoa052187).
  • « The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group », Annals of Internal Medicine, vol. 122, no 8,‎ , p. 561–8 (PMID 7887548, DOI 10.1059/0003-4819-122-8-199504150-00001, lire en ligne).
  • Zhang, Q.L. & Rothenbacher, D., « Prevalence of chronic kidney disease in population-based studies: systematic review », BMC Public Health, vol. 8,‎ , p. 117 (PMID 18405348, PMCID 2377260, DOI 10.1186/1471-2458-8-117).

pubmedcentral.nih.gov

  • Coronary Heart Disease and Physical Activity of Work by J. N. Morris and Margaret D. Crawford, British Medical Journal 1958 ; 2(5111): 1485–1496 [1].

phac-aspc.gc.ca

sciencesetavenir.fr

  • [SEAActu17h-20180924 Maladies non transmissibles : les décès ne diminuent pas assez vite] ; Sciences et Avenir & AFP | 24.09.2018

thelancet.com

un.org

web.archive.org

who.int

who.int

whqlibdoc.who.int

wikiwix.com

archive.wikiwix.com